Clinical Development

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10)colony-forming units

QPS

In a randomized, double-blinded, placebo-controlled trial, the single oral dose typhoid vaccine, M01ZH09, is safe and immunogenic at doses up to 1.7 x 10(10)colony-forming units Read More »

International society of sports nutrition position stand: caffeine and performance

QPS

International society of sports nutrition position stand: caffeine and performance Read More »

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults

QPS

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults Read More »

Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodiumoxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial

QPS

Oxybate SXB-26 Fibromyalgia Syndrome Study Group. Sodiumoxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial Read More »

Randomized Phase II clinical trial of Wellmune WGP® for immune support during cold and flu seasons

QPS

Randomized Phase II clinical trial of Wellmune WGP® for immune support during cold and flu seasons Read More »

A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms

QPS

A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms Read More »

A pilot trial comparing the availability of vitamins C, B6, and B12 from a vitamin-fortified water and food source in humans

QPS

A pilot trial comparing the availability of vitamins C, B6, and B12 from a vitamin-fortified water and food source in humans Read More »

Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)

QPS

Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) Read More »

Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults

QPS

Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults Read More »

Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial

QPS

Effect of a proprietary Magnolia and Phellodendron extract on stress levels in healthy women: a pilot, double-blind, placebo-controlled clinical trial Read More »

Long-term efficacy and safety of lumiracoxib 100 mg: an open-label extension of a 13-week randomized controlled trial in patients with primary osteoarthritis of the knee

QPS

Long-term efficacy and safety of lumiracoxib 100 mg: an open-label extension of a 13-week randomized controlled trial in patients with primary osteoarthritis of the knee Read More »

International Society of Sports Nutrition position stand: Nutrient timing

QPS

International Society of Sports Nutrition position stand: Nutrient timing Read More »

Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial

QPS

Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial Read More »

Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain

QPS

Correlation of measures of pain, function, and overall response: results pooled from two identical studies of etoricoxib in chronic low back pain Read More »

Novel Controlled-Release Lemna-Derived IFN-a2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial

QPS

Novel Controlled-Release Lemna-Derived IFN-a2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial Read More »

Effect of protein source and resistance training on body composition and sex hormones

QPS

Effect of protein source and resistance training on body composition and sex hormones Read More »

Active Renal Secretion of NXY-059, a Novel Neuroprotectant, Is Mediated via an Organic Acid Transporter

QPS

Active Renal Secretion of NXY-059, a Novel Neuroprotectant, Is Mediated via an Organic Acid Transporter Read More »

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies

QPS

Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies Read More »

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib

QPS

Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib Read More »

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus

QPS

Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of SBI-087, a CD20-Directed B-cell Depleting Agent: Phase 1 Dose Escalating Studies in Patients With Either Mild Rheumatoid Arthritis or Systemic Lupus Read More »